e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
The role of hormones and cytokines in lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Compensatory lung growth effects on pulmonary mechanics of emphysematous rats after bilobectomy
F. M. Almeida, B. M. Saraiva-Romanholo, R. D. P. Vieira, H. T. Moriya, A. P. Ligeiro-de-Oliveira, F. D. T. Q. S. Lopes, T. Mauad, M. A. Martins, R. Pazetti (São Paulo, Brazil)
Source:
Annual Congress 2013 –The role of hormones and cytokines in lung injury
Session:
The role of hormones and cytokines in lung injury
Session type:
Thematic Poster Session
Number:
3934
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. M. Almeida, B. M. Saraiva-Romanholo, R. D. P. Vieira, H. T. Moriya, A. P. Ligeiro-de-Oliveira, F. D. T. Q. S. Lopes, T. Mauad, M. A. Martins, R. Pazetti (São Paulo, Brazil). Compensatory lung growth effects on pulmonary mechanics of emphysematous rats after bilobectomy. Eur Respir J 2013; 42: Suppl. 57, 3934
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Immediate post-operative bronchoalveolar neutrophilia is associated with FEV
1
early after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema
Source: Eur Respir J 2005; 25: 275-281
Year: 2005
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
Source: International Congress 2014 – ILDs 3
Year: 2014
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Comparison of pulmonary versus extrapulmonary models of induced acute lung injury in rat
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013
Surfactant changes in patients with lung cancer underwent to resection
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Efficacy of total lung lavage in pulmonary alveolar proteinosis: A multicenter international study of GELF
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 526-531
Year: 2004
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury
Source: Eur Respir J 2003; 21: 495-501
Year: 2003
Early detection of acute lung injury by repeated measurements of airway and tissue mechanics and bronchoalveolar lavage in individual rats
Source: Eur Respir J 2004; 24: Suppl. 48, 335s
Year: 2004
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept